Short answer
Sana Biotechnology, Inc. (SANA) filed an 8-K current report with the SEC on May 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 results released for quarter ended March 31, 2026.
Sana Biotechnology, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results released for quarter ended March 31, 2026
- Press release containing financial figures and management commentary attached as Exhibit 99.1
- Investor focus: quarterly cash position, operating expenses, and clinical-program funding implications
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Sana Biotechnology, Inc. 8-K filings
Get the next SANA 8-K as it lands
Follow SANA for push alerts, or ask the research agent what this filing means.